Purchase Order VA24513P1155

Award Date 4/3/13
Potential Completion Date 4/4/13
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Nashville, TN 37201, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Lundbeck LLC, a foreign-owned for-profit pharmaceutical company. The order is for the delivery of the drug Xenazine, which is used to treat chorea associated with Huntington's disease, for the 2nd quarter of Fiscal Year 2018. The potential value of this order is $106,750.64. Lundbeck holds a five-year Federal Supply Schedule (FSS) contract...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract is for the delivery of Citalopram 40mg, a generic antidepressant medication, with a ceiling value of $90,000.00. This contract was awarded as an unrestricted procurement with no set-aside designation, allowing Exelan to compete based on its capabilities and...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract is for the delivery of Citalopram 40mg, a generic antidepressant medication, with a ceiling value of $77,400.00. The contract was awarded on January 14, 2016 and has an ultimate completion date of the same day, indicating it was likely a one-time or short-term delivery order. The...
This contract was awarded by the Department of Veterans Affairs Veterans Health Administration to Neurocrine Biosciences, Inc., a biopharmaceutical company, for the provision of VALBENAZINE capsules. VALBENAZINE is used to treat neurological movement disorders. The contract was issued as a delivery order against Neurocrine's listing on the General Services Administration's Pharmaceuticals and Drugs schedule contract under the Multiple Award Schedule program. The contract had a firm fixed price...
This firm fixed price delivery order for twenty-four dollars was awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for one hundred tablets of 25mg venlafaxine hydrochloride to be delivered by June 24, 2022 in support of the Agency's pharmaceutical procurement programs. No set aside designation was applied to this order for a generic antidepressant medication. DMS Pharmaceutical Group Inc. will serve as the prime contractor...
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. under an indefinite-delivery/indefinite-quantity contract vehicle. The order is for 120 capsules of XTANDI 40 MG CAPSULE at a firm fixed price of $12,934.05. Performance will take place in Park Ridge, Illinois with completion by March 23, 2023. No set-aside provision was applied to this order. The DLA supports military readiness by procuring and providing medical supplies and pharmaceuticals to armed...
This delivery order, awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., is for the delivery of 120 capsules of XTANDI 40 MG CAPSULE. The potential value of this firm fixed price order is $4,311.35. Performance will occur in Park Ridge, Illinois with an anticipated completion date of October 6, 2023. No set-aside designation was used for this award placed under an unidentified medical supply vehicle. The Defense Logistics Agency Troop Support Medical...
This federal contract award, with ID VA797P14A0003|VA24617E6824, was issued by the Department of Veterans Affairs (VA) to Lundbeck LLC, a global pharmaceutical company. The contract is for the delivery of various pharmaceutical products, including Sabril (vigabatrin) for treatment-resistant seizures, Xenazine (tetrabenazine) for chorea associated with Huntington's disease, and Northera (droxidopa) for neurogenic orthostatic hypotension. The contract, which is not set-aside, has a ceiling value...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order valued at three thousand seven hundred five dollars and eighty-six cents ($3,705.86) to Amerisourcebergen Drug Corporation for ninety (90) tablets of the pharmaceutical escitalopram oxalate, twenty milligrams (20 mg) each. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from June 22, 2023 through June 23,...
The Department of Veterans Affairs Veterans Health Administration awarded a $650,708 delivery order against the Pharmaceuticals and Drugs GSA Schedule to Neurocrine Biosciences, Inc. for the provision of valbenazine for the Hines VA Medical Center in Illinois. Valbenazine is used to treat tardive dyskinesia, an involuntary movement disorder that is a potential side effect of some medications prescribed for mental illness. The firm fixed price order runs from January 7-12, 2021 and will be...

XENAZINE 25MG

Posted 4/3/13, 12:00 AM